Gene: TBL2
Official Full Name: transducin beta like 2provided by HGNC
Gene Summary: This gene encodes a member of the beta-transducin protein family. Most proteins of the beta-transducin family are involved in regulatory functions. This protein is possibly involved in some intracellular signaling pathway. This gene is deleted in Williams-Beuren syndrome, a developmental disorder caused by deletion of multiple genes at 7q11.23. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28017 | TBL2 Knockout cell line (HeLa) | Human | TBL2 | 1:3~1:6 | Negative | Online Inquiry |
KO28018 | TBL2 Knockout cell line (HCT 116) | Human | TBL2 | 1:2~1:4 | Negative | Online Inquiry |
KO28019 | TBL2 Knockout cell line (HEK293) | Human | TBL2 | 1:3~1:6 | Negative | Online Inquiry |
KO28020 | TBL2 Knockout cell line (A549) | Human | TBL2 | 1:3~1:4 | Negative | Online Inquiry |
TBL2 Gene Knockout Cell Lines are precisely engineered cellular models designed to lack the TBL2 gene, a component involved in cellular signaling pathways and regulation. These knockout cell lines serve as essential tools for studying the fundamental roles of TBL2 in various biological processes, such as cell proliferation, differentiation, and apoptosis. By disrupting the TBL2 gene, researchers can elucidate its contributions to cellular functions and disease mechanisms, providing invaluable insights into its involvement in cancer biology and potential therapeutic targets.
The functionality of TBL2 Gene Knockout Cell Lines is rooted in their ability to mimic disease states by effectively removing specific genetic elements. This knockout strategy enables scientists to evaluate the resultant phenotypic changes, assess signaling pathway alterations, and explore potential compensatory mechanisms that might arise from the loss of TBL2. Such cellular models are indispensable for research focused on gene function and the molecular underpinnings of diseases.
In research and clinical settings, TBL2 Gene Knockout Cell Lines offer significant scientific importance, particularly in understanding conditions like cancer, metabolic disorders, and inflammatory diseases where TBL2 may play a critical role. The generation of these cell lines allows for high-throughput screening of drug compounds, facilitating the discovery of new therapeutics and enhancing personalized medicine approaches.
Compared to other available gene knockout models, TBL2 Gene Knockout Cell Lines boast unique advantages such as high specificity for the target gene, reproducibility in experimental outcomes, and compatibility with various assays and analytical techniques. Their use can significantly accelerate research timelines and provide more reliable data that is crucial for downstream applications.
Researchers and clinicians will find tremendous value in utilizing TBL2 Gene Knockout Cell Lines due to their ability to generate meaningful findings that can contribute to novel therapeutic strategies. By investing in these advanced cellular models, users can enhance their experimental robustness and ensure that insights gained are both relevant and impactful.
Our company prides itself on expertise in providing high-quality biological products that empower research and discovery. With a commitment to innovation and excellence, we strive to support the scientific community in unlocking the complexities of gene function and disease understanding.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.